163 related articles for article (PubMed ID: 33673112)
1. Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases.
Galego S; Kauppila LA; Malhó R; Pimentel J; Brito MA
Cells; 2021 Feb; 10(2):. PubMed ID: 33673112
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
[TBL] [Abstract][Full Text] [Related]
3. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB
Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β1 regulates expression of the matrix metalloproteinase 20 (Mmp20) gene through a mechanism involving the transcription factor, myocyte enhancer factor-2C, in ameloblast lineage cells.
Gao Y; Zhang L; Xiang L; Li B; Liu X; Wang Y; Sun Y
Eur J Oral Sci; 2014 Apr; 122(2):114-20. PubMed ID: 24495128
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
[TBL] [Abstract][Full Text] [Related]
6. Myocyte-specific enhancer binding factor 2C expression in human brain development.
Leifer D; Golden J; Kowall NW
Neuroscience; 1994 Dec; 63(4):1067-79. PubMed ID: 7700509
[TBL] [Abstract][Full Text] [Related]
7. Myocyte enhancer factor 2C and its directly-interacting proteins: A review.
Dong C; Yang XZ; Zhang CY; Liu YY; Zhou RB; Cheng QD; Yan EK; Yin DC
Prog Biophys Mol Biol; 2017 Jul; 126():22-30. PubMed ID: 28163053
[TBL] [Abstract][Full Text] [Related]
8. The mammalian target of rapamycin signaling pathway regulates myocyte enhancer factor-2C phosphorylation levels through integrin-linked kinase in goat skeletal muscle satellite cells.
Wu H; Ren Y; Pan W; Dong Z; Cang M; Liu D
Cell Biol Int; 2015 Nov; 39(11):1264-73. PubMed ID: 26041412
[TBL] [Abstract][Full Text] [Related]
9. [β-catenin is involved in BMP9-induced differentiation of C3H10T1/2 cells into cardiomyocyte-like cells].
Fang S; Liu S; Chen Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):750-4. PubMed ID: 27371840
[TBL] [Abstract][Full Text] [Related]
10. Myocyte enhancer factor 2C in hematopoiesis and leukemia.
Canté-Barrett K; Pieters R; Meijerink JP
Oncogene; 2014 Jan; 33(4):403-10. PubMed ID: 23435431
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
Badodi S; Baruffaldi F; Ganassi M; Battini R; Molinari S
Cell Cycle; 2015; 14(10):1517-28. PubMed ID: 25789873
[TBL] [Abstract][Full Text] [Related]
13. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
[TBL] [Abstract][Full Text] [Related]
14. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
15. Role of MEF2C in the Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.
Li T; Conroy KL; Kim AM; Halmai J; Gao K; Moreno E; Wang A; Passerini AG; Nolta JA; Zhou P
Stem Cells; 2023 Apr; 41(4):341-353. PubMed ID: 36639926
[TBL] [Abstract][Full Text] [Related]
16. A p38 Mitogen-Activated Protein Kinase-Regulated Myocyte Enhancer Factor 2-β-Catenin Interaction Enhances Canonical Wnt Signaling.
Ehyai S; Dionyssiou MG; Gordon JW; Williams D; Siu KW; McDermott JC
Mol Cell Biol; 2016 Jan; 36(2):330-46. PubMed ID: 26552705
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
20. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Kentsis A; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
J Hematol Oncol; 2015 Oct; 8():115. PubMed ID: 26487643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
